Awards and Payments Sample Clauses

Awards and Payments. In consideration of the work to be performed under this Agreement as set forth in Exhibit A, Sponsor shall provide financial support for the Study as set forth in the budget (the "Budget") attached hereto as Exhibit B and forming a part of this Agreement. The Budget for the first year of the Study, and extensions mutually agreed upon by the parties, shall be payable in accordance with the payment schedule included in Exhibit B, with the exception that the first such payment by Sponsor to University shall be due ninety (90) days from the Effective Date (as defined in Paragraph 6 below). Subject to the immediately succeeding sentence, the exact Budget for each year of the Study commencing after the first year shall be added to Exhibit at the same time the Research Protocol for such year is added to Exhibit A pursuant to Paragraph 1 and shall be part of the negotiations contemplated in Paragraph 1. Subject to Paragraph 7 of this Agreement, Sponsor shall provide University with sponsored research funding of Xx. Xxxxxxx X. Safe's laboratory at University in the amount of not more than $108,750 for each of the first three agreement years unless such greater amount is mutually agreed to by the parties hereto.
AutoNDA by SimpleDocs
Awards and Payments. In consideration of the work to be performed under this Agreement, Company will provide financial support for the Study as set forth in the Budget attached hereto as Exhibit B. All payments shall be made payable to The Cleveland Clinic Foundation and directed to the following address: X.X. Xxx 000000, Xxxxxxxxx, Xxxx 00000-0000. Each payment voucher should reflect the Company's name, Protocol Number, and name of the Sponsor-Investigator. Institution's Federal Tax Identification Number is: 00-0000000.
Awards and Payments. In consideration of the work to be performed under this Agreement, Sponsor will provide financial support for the Study in the amount of $300,000 with an additional $[***] in indirect costs (for research performed during the time period set forth in paragraph 1 and as more fully set forth in the budget (the "Budget") attached hereto and included as part of Exhibit A. The funding for the first year of the Study shall be made to Rutgers/UMDNJ by Sponsor according to the payment schedule included in Exhibit A, with the exception that the first such payment shall be made within thirty (30) days of the Effective Date (defined in Paragraph 6 below). The Budget and the payment schedule for each year of the Study commencing after the first year shall be added to Exhibit A at the same time the Research Protocol for such year is agreed upon in writing between the parties subsequent to the negotiations contemplated in paragraph 1. Payment for Research Protocols after the first year shall be made thirty (30) days after the Parties have agreed upon such Research Protocols in accordance with the immediately preceding sentence. A portion of the overhead costs normally expected by Rutgers/UMDNJ (57% of the direct costs) shall be deferred according to the following schedule: Year Research Funding Overhead Cost (%) Deferred Overhead (%) ---- ---------------- ----------------- --------------------- 1 $100,000 $[***] $[***] 2 $100,000 $[***] $[***] 3 $100,000 $[***] $[***] The total amount of the non-deferred Research Funding shall be $[***]. The total amount of [***] Confidential Treatment Requested 2 deferred overhead costs during the time period of the Agreement equals $[***]. Sponsor agrees to pay to Rutgers/UMDNJ this amount at such time as (a) Sponsor is selling the Licensed Products under the License Agreement and/or is in receipt of royalty income in excess of $[***] or (b) this Agreement is concluded.
Awards and Payments. Reimbursement will be made for each evaluable patient accrued to this trial at a rate of $ per patient. Payments will be made at the conclusion of each calendar quarter (March, June, September, December) for all evaluable patients accrued. The University of Texas __________ will be reimbursed at a rate of $ per occurrence for all patients not eligible for third party payment upon receipt by SPONSOR of appropriate invoice detailing study number, patient number date and cost of $_____.
Awards and Payments. Awardee agrees to provide payment to the Study Site for Study Site’s milestones during the term of this Agreement, according to the attached benchmark payment schedule, which is incorporated and becomes a part of this Agreement as Exhibit B: Budget and Payment Schedule. Payment will be made to Payee designated in Exhibit C: Payee Information, attached hereto. Study Site certifies that the payment schedule in Exhibit B is adequate remuneration to compensate Study Site for its performance under this Agreement. For invoices and inquiries, please contact: Awardee to insert appropriate invoice and budget contact info here

Related to Awards and Payments

  • Advances and Payments (a) On the date of each Loan, the Administrative Agent shall be authorized (but not obligated) to advance, for the account of each of the Lenders, the amount of the Loan to be made by it in accordance with its Commitment hereunder. Should the Administrative Agent do so, each of the Lenders agrees forthwith to reimburse the Administrative Agent in immediately available funds for the amount so advanced on its behalf by the Administrative Agent, together with interest at the Federal Funds Effective Rate if not so reimbursed on the date due from and including such date but not including the date of reimbursement.

  • Distributions and Payments Section 4.01.

  • Prices and Payments 1. The price listed by the Contractor or otherwise the price commonly charged by the Contractor for the respective service is decisive, plus statutory value-added tax insofar as such is applicable. In case of transnational services, any possibly applicable taxes, fees, customs fees, and other charges (of any kind) incurred for the transnational service shall be borne by the Principal.

  • Fees and Payments Registry Operator shall pay the Registry-Level Fees to ICANN on a quarterly basis in accordance with Section 7.2 hereof.

  • Dividends, Distributions and Payments So long as any Preferred Securities remain outstanding, if there shall have occurred and be continuing an Event of Default or the Guarantor shall have entered into an Extension Period as provided for in the Indenture and such period, or any extension thereof, shall have commenced and be continuing, then the Guarantor may not (a) declare or pay any dividends or distributions on, or redeem, purchase, acquire or make liquidation payment with respect to, any of the Guarantor's capital stock or (b) make any payment of principal of or any interest or premium on or repay, repurchase or redeem any debt securities of the Guarantor that rank pari passu in all respects with or junior in interest to the Preferred Securities (other than (i) repurchases, redemptions or other acquisitions of shares of capital stock of the Guarantor in connection with any employment contract, benefit plan or other similar arrangement with or for the benefit of any one or more employees, officers, directors or consultants, in connection with a dividend reinvestment or stockholder stock purchase plan or in connection with the issuance of capital stock of the Guarantor (or securities convertible into or exercisable for such capital stock) as consideration in an acquisition transaction entered into prior to the occurrence of such Event of Default or the applicable Extension Period, (ii) as a result of an exchange or conversion of any class or series of the Guarantor's capital stock (or any capital stock of a subsidiary of the Guarantor) for any class or series of the Guarantor's capital stock or any class of series of the Guarantor's indebtedness for any class or series of the Guarantor's capital stock, (iii) the purchase of fractional interests in shares of the Guarantor's capital stock pursuant to the conversions or exchange provisions of such capital stock or the security being converted or exchanged, (iv) any declaration of a dividend in connection with any rights plan, the issuance of rights, stock or other property under any rights plan or the redemption or repurchase of rights pursuant thereto, or (v) any dividend in the form of stock, warrants, options or other rights where the dividend stock or the stock issuable upon exercise of such warrants, options or other rights is the same stock as that on which the dividend is being paid or ranks pari passu with or junior to such stock).

  • Compensation and Payment 3.1 Contractor’s fees shall be calculated at the rates set forth in the attached Exhibit

  • Deposits and Payments (a) If Ford Credit’s short term unsecured debt is rated at least “F1” by Fitch and at least “A-1” by Standard & Poor’s (this rating requirement, the “Monthly Deposit Required Ratings”), Ford Credit may deposit Collections on the Business Day preceding each Payment Date, or with satisfaction of the Rating Agency Condition, on each Payment Date.

  • Disbursements and Payments Each disbursement by the Bank and each payment by the Borrower will be:

  • Dividend Payments Except as disclosed in Schedule C, neither the Company nor any subsidiary of the Company is currently prohibited, directly or indirectly, under any order of any Regulatory Agency (other than orders applicable to bank or savings and loan holding companies and their subsidiaries generally), under any applicable law, or under any agreement or other instrument to which it is a party or is subject, from paying any dividends on any of its capital stock (including the Securities in the case of the Company, and any dividends to the Company in the case of any subsidiary of the Company), from making any other distribution on the Company’s or such subsidiary’s capital stock, or in the case of any subsidiary, from repaying to the Company or any other subsidiary of the Company any loans or advances to such subsidiary or from transferring any of such subsidiary’s properties, assets or operations to the Company or any other subsidiary of the Company. As of the date of this Agreement and as further described in Schedule C, the Company has not declared and paid (and has not sought and received any and all necessary regulatory or other approvals to declare and pay), and for the foreseeable future after the date of this Agreement does not intend to declare and pay (and does not intend to seek any and all necessary regulatory or other approvals to declare and pay), each scheduled dividend payment on the Securities.

  • Exchange and Payment (a) Prior to the Effective Time, Parent shall appoint an exchange agent to be mutually agreed by the Parties (the “Exchange Agent”) for the purpose of exchanging for the Merger Consideration certificates representing shares of Company Common Stock (the “Certificates”); provided, however, that any references herein to “Certificates” are deemed to include references to book-entry account statements relating to the ownership of shares of Company Common Stock. Prior to the Effective Time, Parent shall deposit, or shall cause to be deposited, with the Exchange Agent the aggregate per share Merger Consideration (the “Payment Fund”). To the extent such fund diminishes for any reason below the level required to make prompt payment of the Merger Consideration, Parent shall promptly replace or restore, or cause to be replaced or restored, the lost portion of such fund so as to ensure that it is maintained at a level sufficient to make such payments. The Payment Fund shall be invested by the Exchange Agent as directed by Parent; provided that (i) no such investment or losses thereon shall relieve Parent from making the payments required by this Article 2 or affect the amount of Merger Consideration payable hereunder, (ii) no such investment shall have maturities that could prevent or delay payments to be made pursuant to this Agreement and (iii) the Payment Fund shall not be invested in any instruments other than direct short-term obligations of, or short-term obligations fully guaranteed as to principal and interest by, the government of the United States of America, in commercial paper obligations rated A-1 or P-1 or better by Xxxxx’x Investors Service, Inc. or Standard & Poor’s Financial Services LLC, respectively, in certificates of deposit, bank repurchase agreements or bankers’ acceptances of commercial banks with capital exceeding $10 billion (based on the most recent financial statements of such bank that are then publicly available), or in money market funds having a rating in the highest investment category granted by a recognized credit rating agency at the time of investment. Any and all interest or other amounts earned with respect to such funds shall become part of the Payment Fund. The Payment Fund shall not be used for any other purpose. The Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) pay all charges and expenses, including those of the Exchange Agent, in connection with the exchange of shares of Company Common Stock and the payment of the Merger Consideration in respect of such shares of Company Common Stock.

Time is Money Join Law Insider Premium to draft better contracts faster.